Zhejiang Starry Pharmaceutical Co., Ltd. (603520.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 8.38

From 52W high−36.80%

Volume5.86M

Market capCNY 3.81B

P/E (TTM)372.5x

P/S (TTM)1.5x

Div yield3.57%

Key dataSep 18, 2026

Open

CNY 8.38

From 52W high

−36.80%

Volume

5.86M

Market cap

CNY 3.81B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

23.1x

P/E (TTM)

372.5x

RSI (14)

40.3

MomentumView details →

1D Return

−1.92%

YTD Return

−10.64%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

372.5x

EV/EBITDA

23.1x

EV/Sales

2.4x

P/S (TTM)

1.5x

P/B (TTM)

1.6x

ProfitabilityView details →

Gross Margin

21.83%

Net Margin

0.68%

EBITDA Margin

10.44%

ROE (TTM)

0.65%

ROA (TTM)

0.27%

Asset Turnover

0.40x

GrowthView details →

Revenue YoY

+3.23%

EPS YoY

+142.05%

FCF YoY

−39.49%

Revenue CAGR 3Y

+4.70%

EPS CAGR 3Y

−60.78%

EBITDA YoY

—

MomentumView details →

1D Return

−1.92%

YTD Return

−10.64%

1Y Return

−26.83%

RSI (14)

40.3

vs 50D SMA

−4.66%

vs 200D SMA

−16.01%

Capital & dividendView details →

Debt/Equity

1.00x

Current Ratio

1.02x

Quick Ratio

0.53x

Div Yield

3.57%

Div Rate

CNY 0.30

Div Growth 1Y

+100.00%

EarningsView details →

EPS (Actual)

CNY 0.04

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

0.00%

Financials snapshotView financials →

Revenue (TTM)

2.47B

Net Income (TTM)

16.84M

Op. CF (TTM)

−153.53M

Next earningsOct 29, 2026 →

Latest newsMore news →

No recent news for 603520.SH.

Similar companies

灵康药业603669.SH Shandong Xinhua Pharmaceutical Company Limited00719.HK 卫信康603676.SH 康惠股份603139.SH 威尔药业603351.SH Indivior Pharmaceuticals IncINDV Find similar companies →

Latest newsMore news →

No recent news for 603520.SH.